MATALUNI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 8.742
AS - Asia 1.886
EU - Europa 1.654
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 209
AF - Africa 23
OC - Oceania 4
Totale 12.766
Nazione #
US - Stati Uniti d'America 8.687
SG - Singapore 885
IT - Italia 691
CN - Cina 259
RU - Federazione Russa 216
BR - Brasile 209
KR - Corea 177
HK - Hong Kong 163
VN - Vietnam 150
IE - Irlanda 146
DE - Germania 120
GB - Regno Unito 98
UA - Ucraina 93
BD - Bangladesh 87
FR - Francia 74
NL - Olanda 59
JP - Giappone 55
FI - Finlandia 35
CA - Canada 32
IN - India 30
SE - Svezia 22
AT - Austria 19
TR - Turchia 15
CH - Svizzera 14
IQ - Iraq 14
AR - Argentina 13
ES - Italia 11
PL - Polonia 11
RO - Romania 11
ZA - Sudafrica 11
CO - Colombia 7
ID - Indonesia 7
CL - Cile 6
CZ - Repubblica Ceca 6
MX - Messico 6
KG - Kirghizistan 5
MY - Malesia 5
PK - Pakistan 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
BE - Belgio 4
LU - Lussemburgo 4
PH - Filippine 4
AL - Albania 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
IR - Iran 3
PE - Perù 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BS - Bahamas 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.560
Città #
Wilmington 2.269
Houston 1.989
Woodbridge 1.801
Singapore 489
Chandler 262
San Jose 224
Fairfield 176
New York 161
Hong Kong 159
Ashburn 150
Dublin 137
Ann Arbor 112
Beijing 99
Rome 96
Santa Clara 87
Medford 86
Cambridge 72
Seattle 72
Milan 60
Los Angeles 58
The Dalles 55
Dearborn 54
Ho Chi Minh City 53
Tokyo 49
Council Bluffs 48
Jacksonville 48
Lawrence 41
Moscow 40
Dallas 38
Hanoi 38
Lauterbourg 38
Buffalo 34
North Bergen 24
São Paulo 24
Redondo Beach 20
Turin 20
Naples 19
Piove di Sacco 17
Roebling 17
San Diego 17
Bologna 15
Munich 15
Nuremberg 15
Palo Alto 14
London 12
Seoul 12
Atlanta 11
Palermo 11
Florence 10
Orem 10
Lappeenranta 9
Verona 9
Amsterdam 8
Creede 8
Helsinki 8
Montreal 8
Redwood City 8
San Francisco 8
Vienna 8
Basingstoke 7
Haiphong 7
Istanbul 7
Manchester 7
Salt Lake City 7
Warsaw 7
Chennai 6
Elk Grove Village 6
Lodi 6
Mülheim 6
Norwalk 6
Paris 6
Toronto 6
Boston 5
Chengdu 5
Da Nang 5
Kilburn 5
Menlo Park 5
Tooting 5
Vicenza 5
Ankara 4
Belo Horizonte 4
Bergamo 4
Boardman 4
Brno 4
Brooklyn 4
Chicago 4
Columbus 4
Engelhard 4
Erbil 4
Frankfurt am Main 4
Guangzhou 4
Inverigo 4
Jakarta 4
Jinan 4
Johannesburg 4
Karbala 4
Kuala Lumpur 4
Kunming 4
Lausanne 4
Modena 4
Totale 9.655
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 495
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 466
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 461
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 456
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 453
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 439
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 432
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 426
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 424
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 411
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 394
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 383
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 380
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 379
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 351
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 342
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 340
Regional variation of Guillain-Barré syndrome 331
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 323
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 318
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 312
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 268
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 266
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 252
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 244
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 210
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 184
Current treatment practice of Guillain-Barré syndrome 167
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 157
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 150
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 146
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 136
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 134
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 128
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 123
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 117
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 115
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 106
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 105
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 104
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 93
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 87
The neurophysiological lesson from the Italian CIDP database 87
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 83
null 81
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 76
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 74
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 72
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 71
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy 63
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 61
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 59
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 59
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 55
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 54
Impact of environmental factors and physical activity on disability and quality of life in CIDP 53
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 52
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 51
Response to Dr. Wee 49
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 47
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 8
null 3
Totale 12.766
Categoria #
all - tutte 39.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022405 0 35 13 38 24 42 13 19 32 38 28 123
2022/2023851 53 58 100 125 59 159 89 38 79 5 62 24
2023/2024376 62 12 26 22 29 60 27 11 23 22 3 79
2024/20251.448 45 298 155 106 69 130 64 69 164 134 126 88
2025/20262.240 150 92 267 133 219 54 378 227 256 194 171 99
2026/2027168 118 50 0 0 0 0 0 0 0 0 0 0
Totale 12.766